查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1672941

干细胞治疗市场：按细胞来源、应用、最终用户和地区划分

Stem Cell Therapy Market, By Cell Source, By Application, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 153 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年全球干细胞治疗市场规模预估为 186.1 亿美元，预计到 2032 年将达到 783.9 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 22.8%。

报告范围 报告详细信息
基准年 2024 2025 年市场规模 186.1亿美元
效能资料 从 2020 年到 2024 年 预测期 2025 至 2032 年
预测期：2025-2032年复合年增长率： 22.80％ 2032 年价值预测 783.9亿美元
数字。 2025 年干细胞治疗市场占有率（按地区划分）
干细胞治疗市场-IMG1

干细胞治疗是再生医学中一个很有前景的新领域，利用干细胞及其衍生物来修復和再生受损的组织和细胞。从生命的早期阶段开始，所有人类体内都存在干细胞。干细胞具有透过细胞分裂自我更新并分化为多种特殊细胞类型的独特能力。这些细胞透过移植和组织再生，在治疗许多无法治癒的疾病方面具有巨大的潜力。干细胞研究旨在利用干细胞的自然力量来开发可治疗多种疾病的治疗方法，包括癌症、糖尿病、心臟病、骨关节炎和神经系统疾病。

市场动态：

全球干细胞治疗市场的成长受到慢性病增加、干细胞治疗成功率提高、再生医学的快速进步、干细胞治疗研发投入增加以及新治疗方法的核准等因素的推动。然而，干细胞研究、开发和治疗应用的高成本以及与胚胎干细胞相关的伦理问题可能会阻碍市场的成长。新的干细胞来源的开发、高效生产干细胞的先进技术平台的开发、以及应用人工智慧更快地开发客製化的干细胞疗法，都有可能为未来的市场成长提供机会。在全球范围内开发负担得起的干细​​胞疗法和有效的干细胞储存技术将有助于解决尚未满足的需求并扩大市场。

本研究的主要特点

  • 本报告对全球干细胞治疗市场进行了详细分析，并展示了预测期（2025-2032 年）的市场规模（以十亿美元计）和年复合成长率（CAGR%），以 2024 年为基准年。
  • 它还强调了各个领域的潜在收益成长机会，并说明了该市场的引人注目的投资提案矩阵。
  • 它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
  • 本报告根据公司亮点、产品系列、关键亮点、绩效和策略等参数，概述了全球干细胞治疗市场的主要企业。
  • 主要企业：Osiris Therapeutics, Inc.、Kolon TissueGene, Inc.、JCR Pharmaceuticals Co. Ltd.、Pharmacell Co., Inc.、Stemedica Cell Technologies, Inc.、Magellan、Medipost Co. Ltd.、Athersys Inc.、Biorestorative Therapies Inc.、Brainstorm Limited. LTD.、NuVasive Inc.、RTI Surgical、AlloSource
  • 报告中的见解将使负责人和企业经营团队能够就未来产品发布、新兴车型、市场扩张和行销策略做出明智的决策。
  • 全球干细胞治疗市场迎合了该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 相关人员将透过用于分析全球干细胞治疗市场的各种策略矩阵更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规与趋势分析

  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 影响分析
  • 市场趋势
  • 主要进展
  • 监管情景
  • 收购和合作场景
  • 资金筹措和投资
  • PEST分析
  • 波特的分析

4. 全球干细胞治疗市场 - 冠状病毒 (COVID-19) 大流行的影响

  • 整体影响
  • 政府倡议
  • COVID-19 市场影响

5. 全球干细胞治疗市场，依细胞来源，2020-2032 年（十亿美元）

  • 成体干细胞
  • 诱导多功能细胞
  • 胚胎干细胞
  • 其他的

6. 全球干细胞治疗市场，按应用划分，2020-2032 年（十亿美元）

  • 肌肉骨骼疾病
  • 伤口和损伤
  • 癌症
  • 自体免疫疾病
  • 其他的

7. 2020 年至 2032 年全球干细胞治疗市场（按最终用户划分）（十亿美元）

  • 医院
  • 细胞银行
  • 学术研究所

8. 2020 年至 2032 年全球干细胞治疗市场（按地区划分）（十亿美元）

  • 北美洲
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第九章 竞争格局

  • 公司简介
    • Osiris Therapeutics, Inc.
    • Kolon TissueGene, Inc.
    • JCR Pharmaceuticals Co., Ltd.
    • Anterogen Co. Ltd.
    • Pharmicell Co., Inc.
    • Stemedica Cell Technologies, Inc.
    • Magellan
    • Medipost Co., Ltd
    • Athersys Inc.
    • Biorestorative Therapies Inc.
    • Brainstorm Cell Limited.
    • ViaCyte Inc.
    • Cellular Biomedicine Group
    • ANTEROGEN. CO, LTD.
    • NuVasive Inc.
    • RTI Surgical
    • AlloSource

第 10 章分析师建议

  • 机会
  • 分析师观点
  • Coherent Opportunity Map

第 11 章 参考文献与调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI2848

Global Stem Cell Therapy Market is estimated to be valued at USD 18.61 Bn in 2025 and is expected to reach USD 78.39 Bn by 2032, growing at a compound annual growth rate (CAGR) of 22.8% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 18.61 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 22.80% 2032 Value Projection: USD 78.39 Bn
Figure. Stem Cell Therapy Market Share (%), By Region 2025
Stem Cell Therapy Market - IMG1

Stem cell therapy is a promising and emerging field in regenerative medicine that involves the use of stem cells and their derivatives to repair or regenerate damaged tissues and cells. Stem cells are found in all human beings from a very early stage of life. These have the unique ability to renew themselves through cell division and differentiate into a diverse range of specialized cell types. These cells hold great potential to treat many incurable diseases through transplantation or tissue regeneration. Stem cell research aims to harness the natural powers of stem cells to develop therapies that can cure various diseases like cancer, diabetes, heart disease, osteoarthritis and neurological disorders.

Market Dynamics:

Global stem cell therapy market growth is driven by factors such as rising prevalence of chronic diseases, increasing success rates of stem cell therapies, rapid advancements in regenerative medicine, growing investments for research and development in stem cell therapies and approval of new therapies. However, high costs involved in stem cell research & development and therapeutic applications along with ethical issues related to embryonic stem cells can hamper the market growth. Emergence of new stem cell sources, development of advanced technology platforms for efficient production of stem cells, and application of artificial intelligence for faster development of customized stem cell therapies can offer opportunities for the market growth in the future. Providing affordable stem cell therapies globally and developing efficient techniques for stem cell banking can help to address unmet needs and expand the market reach.

Key Features of the Study:

  • This report provides an in-depth analysis of the global stem cell therapy market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global stem cell therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this includes Osiris Therapeutics, Inc., Kolon TissueGene, Inc., JCR Pharmaceuticals Co., Ltd., Anterogen Co. Ltd., Pharmicell Co., Inc., Stemedica Cell Technologies, Inc., Magellan, Medipost Co., Ltd, Athersys Inc., Biorestorative Therapies Inc., Brainstorm Cell Limited., ViaCyte Inc., Cellular Biomedicine Group, ANTEROGEN. C.O., LTD., NuVasive Inc., RTI Surgical, AlloSource.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global stem cell therapy market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global stem cell therapy market.

Detailed Segmentation-

  • By Cell Source:
    • Adult Stem Cells
    • Induced Pluripotent Stem Cells
    • Embryonic Stem Cells
    • Others
  • By Application:
    • Musculoskeletal Disorders
    • Wounds and Injuries
    • Cancer
    • Autoimmune Disorders
    • Others
  • By End User:
    • Hospitals
    • Cell Banks
    • Academic and Research Institutes
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Osiris Therapeutics, Inc.
    • Kolon TissueGene, Inc.
    • JCR Pharmaceuticals Co., Ltd.
    • Anterogen Co. Ltd.
    • Pharmicell Co., Inc.
    • Stemedica Cell Technologies, Inc.
    • Magellan
    • Medipost Co., Ltd
    • Athersys Inc.
    • Biorestorative Therapies Inc.
    • Brainstorm Cell Limited.
    • ViaCyte Inc.
    • Cellular Biomedicine Group
    • C.O., LTD.
    • NuVasive Inc.
    • RTI Surgical
    • AlloSource

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Cell Source
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Stem Cell Therapy Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Stem Cell Therapy Market, By Cell Source, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Adult Stem Cells
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Induced Pluripotent Stem Cells
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Embryonic Stem Cells
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Stem Cell Therapy Market, By Application, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Musculoskeletal Disorders
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Wounds and Injuries
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Cancer
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Autoimmune Disorders
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Stem Cell Therapy Market, By End User, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Hospitals
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Cell Banks
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Academic and Research Institutes
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Stem Cell Therapy Market, By Region, 2020 - 2032, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • Osiris Therapeutics, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Kolon TissueGene, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • JCR Pharmaceuticals Co., Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Anterogen Co. Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Pharmicell Co., Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Stemedica Cell Technologies, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Magellan
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Medipost Co., Ltd
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Athersys Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Biorestorative Therapies Inc.
    • Brainstorm Cell Limited.
    • ViaCyte Inc.
    • Cellular Biomedicine Group
    • ANTEROGEN. C.O., LTD.
    • NuVasive Inc.
    • RTI Surgical
    • AlloSource

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact